<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>49(5)</volume><submitter>Melchor-Lopez A</submitter><pubmed_abstract>&lt;h4>Objectives&lt;/h4>We aimed to determine whether parameters associated with adipose tissue (adipocyte density and the circulating concentrations of markers of adipose tissue pathology) predict cardiovascular risk (CVR) modification after metabolic surgery (MS).&lt;h4>Methods&lt;/h4>We performed a case-control study of patients with morbid obesity who were candidates for MS. CVR was defined using flow-mediated dilation (FMD) and carotid intima media thickness (CIMT), which were measured during the 9 months following MS. Subgroups of CVR reduction were defined using the following cut-offs: CIMT 10% and/or a two-fold increase in FMD.&lt;h4>Results&lt;/h4>We studied 40 patients with morbid obesity (mean age 44.5 years, 75% women, mean body mass index 46.4 kg/m&lt;sup>2&lt;/sup>) and high prevalences of the meta</pubmed_abstract><journal>The Journal of international medical research</journal><pagination>3000605211012569</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8150427</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Identification of adipose tissue-related predictors of the reduction in cardiovascular risk induced by metabolic surgery.</pubmed_title><pmcid>PMC8150427</pmcid><pubmed_authors>Salamanca-Garcia M</pubmed_authors><pubmed_authors>Gutierrez-Buendia JA</pubmed_authors><pubmed_authors>Pena-Sosa G</pubmed_authors><pubmed_authors>Gaytan-Fuentes OF</pubmed_authors><pubmed_authors>Vera-Gomez E</pubmed_authors><pubmed_authors>Alcaraz-Estrada SL</pubmed_authors><pubmed_authors>Pineda-Juarez JA</pubmed_authors><pubmed_authors>Hernandez-Patricio A</pubmed_authors><pubmed_authors>Garcia S</pubmed_authors><pubmed_authors>Perez-Cabeza de Vaca R</pubmed_authors><pubmed_authors>Mondragon-Teran P</pubmed_authors><pubmed_authors>Tellez-Gonzalez MA</pubmed_authors><pubmed_authors>Zamora-Aleman CR</pubmed_authors><pubmed_authors>Banderas-Lares DZ</pubmed_authors><pubmed_authors>Suarez-Cuenca JA</pubmed_authors><pubmed_authors>Contreras-Ramos A</pubmed_authors><pubmed_authors>Montoya-Ramirez J</pubmed_authors><pubmed_authors>Rodriguez-Arellano ME</pubmed_authors><pubmed_authors>Melchor-Lopez A</pubmed_authors><pubmed_authors>Escamilla-Tilch M</pubmed_authors><pubmed_authors>Ortiz-Fernandez M</pubmed_authors><pubmed_authors>Hernandez-Munoz RE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification of adipose tissue-related predictors of the reduction in cardiovascular risk induced by metabolic surgery.</name><description>&lt;h4>Objectives&lt;/h4>We aimed to determine whether parameters associated with adipose tissue (adipocyte density and the circulating concentrations of markers of adipose tissue pathology) predict cardiovascular risk (CVR) modification after metabolic surgery (MS).&lt;h4>Methods&lt;/h4>We performed a case-control study of patients with morbid obesity who were candidates for MS. CVR was defined using flow-mediated dilation (FMD) and carotid intima media thickness (CIMT), which were measured during the 9 months following MS. Subgroups of CVR reduction were defined using the following cut-offs: CIMT 10% and/or a two-fold increase in FMD.&lt;h4>Results&lt;/h4>We studied 40 patients with morbid obesity (mean age 44.5 years, 75% women, mean body mass index 46.4 kg/m&lt;sup>2&lt;/sup>) and high prevalences of the meta</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 May</publication><modification>2025-04-04T14:20:39.406Z</modification><creation>2022-02-10T14:08:07.958Z</creation></dates><accession>S-EPMC8150427</accession><cross_references><pubmed>34024182</pubmed><doi>10.1177/03000605211012569</doi></cross_references></HashMap>